Hansoh Pharma's Lock-Up Expiry: Valuation and the Trade
Lock-up restriction for Hansoh Pharma's controlling shareholder, pre-IPO investors and cornerstone investors will expire on December 14th. We...
583 Views
Hansoh Pharma's Lock-Up Expiry - New Drugs Offset the Impact of Centralized Procurement
Lock-up restriction for Hansoh Pharma's controlling shareholder, pre-IPO investors and cornerstone investors will expire on December 14th. As we...
561 Views
HK Connect Flows: Close Meituan/Elong Trade with a 14.5% Profit
In our weekly HK Connect Flow series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed...
406 Views
HSCEI Rebalance - The Names They Are a Changin'
The Hang Seng Indexes Company Limited (HSIL) announced the results of its review of the Hang Seng Family of Indexes on Friday post market close....
604 Views
Innovent Biologics - Promising Phase I Results for Lung Cancer
In the recent 2019 World Conference on Lung Cancer held in Spain, Innovent Biologics reported preliminary results from a Phase I clinical trial on...
484 Views